Respiratory markers
Respiratory diseases, or lung diseases, are pathological conditions affecting the organs and tissues that make gas exchange difficult in air-breathing animals. They include conditions of the respiratory tract including the trachea, bronchi, bronchioles, alveoli, pleurae, pleural cavity, the nerves and muscles of respiration. Respiratory diseases range from mild and self-limiting, such as the common cold, influenza, and pharyngitis to life-threatening diseases such as bacterial pneumonia, pulmonary embolism, tuberculosis, acute asthma, lung cancer, and severe acute respiratory syndromes, such as COVID-19.
- Product name
- Catalog NO.
- Source
- Usage
- Platform
- Human ACE2-hFc Recombinant Protein AGACE202
- Catalog NO. AGACE202
- Source HEK293
- Usage Coating
- Platform GICA, FIA, CLIA, ELISA
- Human ACE2 Recombinant Protein AGACE201
- Catalog NO. AGACE201
- Source HEK293
- Usage Coating
- Platform GICA, FIA, CLIA, ELISA
- SARS-COV-2 Nucleocapsid Recombinant Protein AGCOVN01
- Catalog NO. AGCOVN01
- Source E.coli
- Usage Labeling
- Platform GICA, FIA, CLIA, ELISA
- SARS-COV-2 Spike RBD Recombinant Protein AGCOVS01
- Catalog NO. AGCOVS01
- Source HEK293
- Usage Labeling
- Platform GICA, FIA, CLIA, ELISA
- SARS-COV-2 Spike RBD Recombinant Protein AGCOVS02
- Catalog NO. AGCOVS02
- Source HEK293
- Usage Labeling
- Platform GICA, FIA, CLIA, ELISA
- SARS-COV-2 S1 Recombinant Protein (high purity) AGCOVS05
- Catalog NO. AGCOVS05
- Source HEK293
- Usage
- Platform GICA, FIA, CLIA, ELISA
- SARS-COV-2 S1 Recombinant Protein AGCOVS04
- Catalog NO. AGCOVS04
- Source HEK293
- Usage
- Platform GICA, FIA, CLIA, ELISA
Shenzhen AIVD Biotechnology Co. , LTD.
A4 Building 4th Floor / B5 Building C501, China Merchants Bright Technology Park, Fenghuang Street, Guangming District, Shenzhen, Guangdong Province, China
E-mail:
market@aivdbiotech.com
info@aivdbiotech.com
Tel: +86-755-26165742 +86 18543132823
WhatsApp:+86 18543132823
© 2022 Shenzhen AIVD Biotechnology Co.,LTD. 粤ICP备18093805号